Wall Street analyst estimates for NRC Health (NRC): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
National Research Corporation (NRC) empowers healthcare organizations across the United States and Canada with data-driven analytics and actionable insights to enhance both patient and employee experiences.
Valuation Ratios
| P/E Ratio | 84.00 |
| Price / Book | 74.10 |
| EV / EBITDA | 24.03 |
| Dividend Yield | 2.72% |
Income Statement (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $109.4M | $117.6M | $119.7M | $128.0M | $133.3M | $148.0M | $151.6M | $148.6M | $143.1M | $137.4M |
| Cost of Revenue | $45.6M | $49.1M | $47.6M | $46.4M | $49.2M | $52.4M | $57.0M | $56.0M | $56.9M | $60.0M |
| Gross Profit | $63.8M | $68.5M | $72.1M | $81.5M | $84.1M | $95.6M | $94.5M | $92.6M | $86.1M | $77.4M |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | $28.4M | $29.7M | $31.4M | $33.0M | $34.4M | $39.0M | $42.7M | $46.6M | $44.9M | $54.8M |
| Operating Expenses | $32.6M | $34.3M | $36.8M | $38.5M | $41.4M | $45.3M | $48.0M | $52.5M | $50.9M | $54.8M |
| Operating Income | $31.2M | $34.2M | $35.3M | $43.0M | $42.7M | $50.3M | $46.5M | $40.0M | $35.2M | $22.6M |
| EBITDA | $35.8M | $39.0M | $41.7M | $48.6M | $50.8M | $56.7M | $49.3M | $46.0M | $41.3M | $30.2M |
| Interest Expense | $190000 | $82000 | $1.5M | $2.1M | $1.8M | $1.7M | $1.2M | $862000 | $2.6M | $4.8M |
| Pre-tax Income | $31.4M | $34.3M | $34.7M | $40.5M | $41.5M | $48.6M | $42.8M | $40.0M | $32.7M | $17.8M |
| Income Tax | $10.8M | $11.3M | $4.7M | $8.1M | $4.2M | $11.2M | $11.0M | $9.0M | $7.9M | $6.2M |
| Net Income | $20.5M | $22.9M | $30.0M | $32.4M | $37.3M | $37.5M | $31.8M | $31.0M | $24.8M | $11.6M |
| EPS | $0.49 | $0.54 | $1.11 | $1.30 | $1.48 | $1.47 | $1.28 | $1.26 | $1.05 | $0.52 |
| EPS (Diluted) | $0.48 | $0.52 | $1.07 | $1.26 | $1.45 | $1.46 | $1.27 | $1.25 | $1.04 | $0.52 |
| Shares Outstanding (Diluted) | $24.6M | $25.2M | $28.1M | $25.7M | $25.7M | $25.6M | $25.1M | $24.7M | $23.7M | $22.4M |
Price
| Price | $22.05 |
| Market Cap | $497M |
| Exchange | NASDAQ |
| Country | US |
Related companies: DH · HCAT · NNOX · PBYI · QTRX · SNWV · SOPH
Explore sector: Healthcare · Medical - Healthcare Information Services
More sections of NRC: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks